Amarin picks Colin Stewart as president, CEO

Amarin has tapped Colin Stewart as president, CEO and a member of the company's board of directors. Amarin release

SkyePharma has appointed Axel Müller as CEO with effect from Aug. 23. Skyepharma release

Werner Cautreels has been selected as president and CEO of Selecta Biosciences, a biopharmaceutical company developing synthetic nanoparticle vaccines and immunotherapies. Selecta release

Alimera Sciences has promoted Richard Eiswirth, Jr. to chief operating officer and David Holland to senior VP of sales and marketing. Alimera release

Genocea Biosciences has named Chip Clark to the position of chief business officer. Genocea release

Darl Moreland has joined Alexza Pharmaceuticals as VP, Quality. Alexa release

Human Genome Sciences has named Tuomo Pätsi VP, HGS Europe. HGS release

Curaxis Pharmaceutical has elected Bert Spilker to its board of directors. Curaxis release

GenSpera has appointed Bo Jesper Hansen to its board of directors. Hansen replaces John Farah, Jr., a board member since 2008, who has resigned due to a change in his employer's policy regarding outside directorships. GenSpera release

Suggested Articles

Preclinical-stage biotech Abpro Therapeutics wants to trial its two lead candidates for HER2-positive cancers and diabetic macular edema in 2019.

After a rough patch in 2017, the stars seem to be realigning for French CAR-T expert Cellectis, which just closed a $164 million U.S. public offering.

Investment firm Frazier Healthcare Partners has closed its 11th fund—worth $780 million—that will help established companies accelerate their growth.